Metabolic engineering for plant natural product biosynthesis in microbes

Current Opinion in Biotechnology

Volumn 19, Issue 6, 2008, Pages 597-605

  Chemler, Joseph A ^a   Koffas, Mattheos AG ^a  

^a the State University of New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOSYNTHESIS; GENETIC ENGINEERING; SYNTHESIS (CHEMICAL);

BIOSYNTHETIC PATHWAYS; CHEMICAL SYNTHESES; CODON OPTIMIZATIONS; COMBINATORIAL BIOSYNTHESES; COMPLEX STRUCTURES; ISOPRENOIDS; METABOLIC ENGINEERINGS; NATURAL PRODUCTS; PHARMACOLOGICAL ACTIVITIES; PHENYLPROPANOIDS; PROTEIN ENGINEERINGS; REGIONAL VARIATIONS; REGULATORY ELEMENTS; RENEWABLE RESOURCES; TECHNOLOGICAL PLATFORMS;

BIOCHEMICAL ENGINEERING;

ALKALOID DERIVATIVE; ARTEMISININ; BENZYLISOQUINOLINE DERIVATIVE; BERBERINE; CAROTENOID; CYTOCHROME P450; FLAVONOID; ISOPRENOID; LYCOPENE; NATURAL PRODUCT; PACLITAXEL; SANGUINARINE; STILBENE DERIVATIVE; TETRAHYDROPAPAVEROLINE;

ANTIOXIDANT ACTIVITY; ARTEMISIA AMNUA; BIOSYNTHESIS; BREAST CANCER; DRUG STRUCTURE; MEDICINAL PLANT; METABOLIC ENGINEERING; MICROORGANISM; OVARY CANCER; PLANT PRODUCT; PRIORITY JOURNAL; PROTEIN ENGINEERING; REVIEW; TAXUS BREVIFOLIA;

BIOLOGICAL PRODUCTS; BIOTECHNOLOGY; PLANTS;

EID: 57649100762     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2008.10.011     Document Type: Review

References (69)

1. Williams D.H., Stone M.J., Hauck P.R., and Rahman S.K. Why are secondary metabolites (natural products) biosynthesized?. J Nat Prod 52 (1989) 1189-1208
2. Firn R.D., and Jones C.G. Do we need a new hypothesis to explain plant VOC emissions?. Trends Plant Sci 11 (2006) 112-113 author reply 113-114
3. Fischbach M.A., and Clardy J. One pathway, many products. Nat Chem Biol 3 (2007) 353-355
4. Newman D.J., and Cragg G.M. Natural products as sources of new drugs over the last 25 years. J Nat Prod 70 (2007) 461-477. The authors have provided an updated analysis of the commercially available pharmaceuticals brought to market over the past 25 years. Special focus is put on categorizing the structural origins of the drugs especially highlighting the significant role NPs play in the drug discovery process, while the current combinatorial and discovery platform is questioned.
5. Schmid R. Pocket Guide to Biotechnology and Genetic Engineering (2003), Wiley-VCH, Weinheim [Germany]
6. Feher M., and Schmidt J.M. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci 43 (2003) 218-227
7. Baltz R.H. Marcel Faber Roundtable: is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration?. J Ind Microbiol Biotechnol 33 (2006) 507-513
8. Paterson I., and Anderson E.A. Chemistry. The renaissance of natural products as drug candidates. Science 310 (2005) 451-453
9. Nicolaou K.C., Yang Z., Liu J.J., Ueno H., Nantermet P.G., Guy R.K., Claiborne C.F., Renaud J., Couladouros E.A., Paulvannan K., et al. Total synthesis of Taxol. Nature 367 (1994) 630-634
10. Wu S., and Chappell J. Metabolic engineering of natural products in plants; tools of the trade and challenges for the future. Curr Opin Biotechnol 19 (2008) 145-152
11. Zhang W., and Tang Y. Combinatorial biosynthesis of natural products. J Med Chem 51 (2008) 2629-2633
12. Holtorf H., Guitton M.C., and Reski R. Plant functional genomics. Naturwissenschaften 89 (2002) 235-249
13. Hunter I.S. Microbial synthesis of secondary metabolites and strain improvement. In: El-Mansi E.M.T., Bryce C.F.A., Hartley B.S., and Demain A.L. (Eds). Fermentation Microbiology and Biotechnology. edn 2 (2007), CRC/Taylor & Francis 131-158
14. Kingston D.G. Recent advances in the chemistry of Taxol. J Nat Prod 63 (2000) 726-734
15. McCoy M. Lining up to make a cancer drug. Chem Eng News 82 (2004) 12-14
16. Kaspera R., and Croteau R. Cytochrome P450 oxygenases of Taxol biosynthesis. Phytochem Rev 5 (2006) 433-444
17. Rontein D., Onillon S., Herbette G., Lesot A., Werck-Reichhart D., Sallaud C., and Tissier A. CYP725A4 from yew catalyzes complex structural rearrangement of taxa-4(5) 11(12)-diene into the cyclic ether 5(12)-oxa-3(11)-cyclotaxane. J Biol Chem 283 (2008) 6067-6075
18. Jennewein S., Park H., DeJong J.M., Long R.M., Bollon A.P., and Croteau R.B. Coexpression in yeast of Taxus cytochrome P450 reductase with cytochrome P450 oxygenases involved in Taxol biosynthesis. Biotechnol Bioeng 89 (2005) 588-598
19. Jennewein S., Wildung M.R., Chau M., Walker K., and Croteau R. Random sequencing of an induced Taxus cell cDNA library for identification of clones involved in Taxol biosynthesis. Proc Natl Acad Sci U S A 101 (2004) 9149-9154
20. Dejong J.M., Liu Y., Bollon A.P., Long R.M., Jennewein S., Williams D., and Croteau R.B. Genetic engineering of taxol biosynthetic genes in Saccharomyces cerevisiae. Biotechnol Bioeng 93 (2006) 212-224
21. Engels B., Dahm P., and Jennewein S. Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (Paclitaxel) production. Metab Eng 10 (2008) 201-206. This paper presents the highest production levels achieved so far in a recombinant microbial host. These authors used a combination of heterologous expression of the preliminary Taxol biosynthesis pathway and used regulatory elements to downregulate competitive pathways.
22. Schmid G., and Hofeinz W. Total synthesis of Qinghaosu. J Am Chem Soc 105 (1983) 624-625
23. Roth R.J., and Acton N. A simple conversion of artemisinic acid into artemisinin. J Nat Prod 52 (1989) 1183-1185
24. Lindahl A.L., Olsson M.E., Mercke P., Tollbom O., Schelin J., Brodelius M., and Brodelius P.E. Production of the artemisinin precursor amorpha-4,11-diene by engineered Saccharomyces cerevisiae. Biotechnol Lett 28 (2006) 571-580
25. Ro D.K., Paradise E.M., Ouellet M., Fisher K.J., Newman K.L., Ndungu J.M., Ho K.A., Eachus R.A., Ham T.S., Kirby J., et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440 (2006) 940-943. These authors describe the construction of a recombinant yeast strain for the production of artemisinic acid for the first time. This was achieved by increasing metabolic flux through the MEV pathway and discovery and use of a P450 monooxygenase capable of converting amorpha-4,11-diene into artemisinic acid through a three step catalytic reaction.
26. Alper H., Miyaoku K., and Stephanopoulos G. Characterization of lycopene-overproducing E. coli strains in high cell density fermentations. Appl Microbiol Biotechnol 72 (2006) 968-974
27. Pitera D.J., Paddon C.J., Newman J.D., and Keasling J.D. Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metab Eng 9 (2007) 193-207
28. Newman J.D., Marshall J., Chang M., Nowroozi F., Paradise E., Pitera D., Newman K.L., and Keasling J.D. High-level production of amorpha-4,11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli. Biotechnol Bioeng 95 (2006) 684-691
29. Martin V.J., Pitera D.J., Withers S.T., Newman J.D., and Keasling J.D. Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nat Biotechnol 21 (2003) 796-802
30. Chang M.C., Eachus R.A., Trieu W., Ro D.K., and Keasling J.D. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nat Chem Biol 3 (2007) 274-277
31. Rao A.V., and Rao L.G. Carotenoids and human health. Pharmacol Res 55 (2007) 207-216
32. Lotan T., and Hirschberg J. Cloning and expression in Escherichia coli of the gene encoding beta-C-4-oxygenase, that converts beta-carotene to the ketocarotenoid canthaxanthin in Haematococcus pluvialis. FEBS Lett 364 (1995) 125-128
33. Kang M.J., Lee Y.M., Yoon S.H., Kim J.H., Ock S.W., Jung K.H., Shin Y.C., Keasling J.D., and Kim S.W. Identification of genes affecting lycopene accumulation in Escherichia coli using a shot-gun method. Biotechnol Bioeng 91 (2005) 636-642
34. Alper H., Miyaoku K., and Stephanopoulos G. Construction of lycopene-overproducing E. coli strains by combining systematic and combinatorial gene knockout targets. Nat Biotechnol 23 (2005) 612-616. The authors used a combination of rational and combinatorial methods to construct several E. coli mutant strains capable of producing elevated levels of lycopene.
35. Jin Y.S., and Stephanopoulos G. Multi-dimensional gene target search for improving lycopene biosynthesis in Escherichia coli. Metab Eng 9 (2007) 337-347
36. Forkmann G., and Martens S. Metabolic engineering and applications of flavonoids. Curr Opin Biotechnol 12 (2001) 155-160
37. Ro D.K., and Douglas C.J. Reconstitution of the entry point of plant phenylpropanoid metabolism in yeast (Saccharomyces cerevisiae): implications for control of metabolic flux into the phenylpropanoid pathway. J Biol Chem 279 (2004) 2600-2607
38. Vannelli T., Wei Qi W., Sweigard J., Gatenby A.A., and Sariaslani F.S. Production of p-hydroxycinnamic acid from glucose in Saccharomyces cerevisiae and Escherichia coli by expression of heterologous genes from plants and fungi. Metab Eng 9 (2007) 142-151
39. Jiang H., Wood K.V., and Morgan J.A. Metabolic engineering of the phenylpropanoid pathway in Saccharomyces cerevisiae. Appl Environ Microbiol 71 (2005) 2962-2969
40. Yan Y., Kohli A., and Koffas M.A. Biosynthesis of natural flavanones in Saccharomyces cerevisiae. Appl Environ Microbiol 71 (2005) 5610-5613
41. Yan Y., Huang L., and Koffas MA. Biosynthesis of 5-deoxyflavanones in microorganisms. Biotechnol J 2 (2007) 1250-1262
42. Leonard E., Yan Y., Lim K.H., and Koffas MA. Investigation of two distinct flavone synthases for plant-specific flavone biosynthesis in Saccharomyces cerevisiae. Appl Environ Microbiol 71 (2005) 8241-8248
43. Miyahisa I., Funa N., Ohnishi Y., Martens S., Moriguchi T., and Horinouchi S. Combinatorial biosynthesis of flavones and flavonols in Escherichia coli. Appl Microbiol Biotechnol 71 (2006) 53-58
44. Leonard E., Chemler J., Lim K.H., and Koffas MA. Expression of a soluble flavone synthase allows the biosynthesis of phytoestrogen derivatives in Escherichia coli. Appl Microbiol Biotechnol 70 (2006) 85-91
45. Katsuyama Y., Funa N., Miyahisa I., and Horinouchi S. Synthesis of unnatural flavonoids and stilbenes by exploiting the plant biosynthetic pathway in Escherichia coli. Chem Biol 14 (2007) 613-621
46. Chemler J.A., Lock L.T., Koffas M.A., and Tzanakakis E.S. Standardized biosynthesis of flavan-3-ols with effects on pancreatic beta-cell insulin secretion. Appl Microbiol Biotechnol 77 (2007) 797-807
47. Yan Y., Li Z., and Koffas M.A. High-yield anthocyanin biosynthesis in engineered Escherichia coli. Biotechnol Bioeng 100 (2008) 126-140
48. Leonard E., Yan Y., Fowler Z.L., Li Z., Lim C.G., Lim K.H., and Koffas M.A. Strain improvement of recombinant Escherichia coli for efficient production of plant flavonoids. Mol Pharm 5 (2008) 257-265
49. Leonard E., Lim K.H., Saw P.N., and Koffas M.A. Engineering central metabolic pathways for high-level flavonoid production in Escherichia coli. Appl Environ Microbiol 73 (2007) 3877-3886. A combination of overexpressions around the acetate assimulation/malonyl-CoA node was employed for increasing carbon flux toward malonyl-CoA. This resulted in produced flavanone concentrations of up to 480 mg/L.
50. Chemler J.A., Yan Y., Leonard E., and Koffas M.A. Combinatorial mutasynthesis of flavonoid analogues from acrylic acids in microorganisms. Org Lett 9 (2007) 1855-1858
51. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (1997) 218-220
52. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
53. Valenzano D.R., Terzibasi E., Genade T., Cattaneo A., Domenici L., and Cellerino A. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol 16 (2006) 296-300
54. Kaeberlein M., McDonagh T., Heltweg B., Hixon J., Westman E.A., Caldwell S.D., Napper A., Curtis R., DiStefano P.S., Fields S., et al. Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 280 (2005) 17038-17045
55. Zhang Y., Li S.Z., Li J., Pan X., Cahoon R.E., Jaworski J.G., Wang X., Jez J.M., Chen F., and Yu O. Using unnatural protein fusions to engineer resveratrol biosynthesis in yeast and mammalian cells. J Am Chem Soc 128 (2006) 13030-13031
56. Beekwilder J., Wolswinkel R., Jonker H., Hall R., de Vos C.H., and Bovy A. Production of resveratrol in recombinant microorganisms. Appl Environ Microbiol 72 (2006) 5670-5672
57. Hughes E.H., and Shanks J.V. Metabolic engineering of plants for alkaloid production. Metab Eng 4 (2002) 41-48
58. Sato F., Inui T., and Takemura T. Metabolic engineering in isoquinoline alkaloid biosynthesis. Curr Pharm Biotechnol 8 (2007) 211-218
59. McCoy E., and O'Connor S.E. Directed biosynthesis of alkaloid analogs in the medicinal plant Catharanthus roseus. J Am Chem Soc 128 (2006) 14276-14277
60. Bernhardt P., McCoy E., and O'Connor S.E. Rapid identification of enzyme variants for reengineered alkaloid biosynthesis in periwinkle. Chem Biol 14 (2007) 888-897
61. Minami H., Kim J.S., Ikezawa N., Takemura T., Katayama T., Kumagai H., and Sato F. Microbial production of plant benzylisoquinoline alkaloids. Proc Natl Acad Sci U S A 105 (2008) 7393-7398. These authors introduced benzylisoquinoline alkaloid biosynthetic genes in order to produce the core alkaloid, reticuline, in E. coli for the first time. They also expanded the biosynthesis of other benzylisoquinoline alkaloids.
62. Hawkins K.M., and Smolke C.D. Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae. Nat Chem Biol 4 (2008) 564-573. These authors engineered yeast strains expressing combinations of enzymes from three plant sources and humans as microbial hosts for the production of a wide array of benzylisoquinoline alkaloid metabolites. Notably, they report relatively high titers of reticuline.
63. Chen H., Jiang H., and Morgan J.A. Non-natural cinnamic acid derivatives as substrates of cinnamate 4-hydroxylase. Phytochemistry 68 (2007) 306-311
64. Gillam E.M. Engineering cytochrome p450 enzymes. Chem Res Toxicol 21 (2008) 220-231
65. Barnes H.J., Arlotto M.P., and Waterman M.R. Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli. Proc Natl Acad Sci U S A 88 (1991) 5597-5601
66. Leonard E., Yan Y., and Koffas M.A. Functional expression of a P450 flavonoid hydroxylase for the biosynthesis of plant-specific hydroxylated flavonols in Escherichia coli. Metab Eng 8 (2006) 172-181
67. Leonard E., and Koffas M.A. Engineering of artificial plant cytochrome P450 enzymes for synthesis of isoflavones by Escherichia coli. Appl Environ Microbiol 73 (2007) 7246-7251
68. Tian L., and Dixon R.A. Engineering isoflavone metabolism with an artificial bifunctional enzyme. Planta 224 (2006) 496-507
69. Landwehr M., Carbone M., Otey C.R., Li Y., and Arnold F.H. Diversification of catalytic function in a synthetic family of chimeric cytochrome p450s. Chem Biol 14 (2007) 269-278